3,n(4)-ethenodeoxycytidine has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banaszkiewicz, Z; Bartsch, H; Cadet, J; Chaber, A; Cieśla, JM; Douki, T; Gackowski, D; Janik, J; Janowska, B; Jawien, A; Kowalczyk, P; Krasnodebski, I; Nair, J; Obtułowicz, T; Olinski, R; Speina, E; Swoboda, M; Tudek, B; Winczura, A | 1 |
1 other study(ies) available for 3,n(4)-ethenodeoxycytidine and Carcinoma
| Article | Year |
|---|---|
Aberrant repair of etheno-DNA adducts in leukocytes and colon tissue of colon cancer patients.
Topics: Adult; Aged; Carcinoma; Case-Control Studies; Colon; Colonic Neoplasms; Deoxyadenosines; Deoxycytidine; DNA Adducts; DNA Glycosylases; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Female; Humans; Leukocytes, Mononuclear; Lipid Peroxidation; Middle Aged; Mutation; Thymine DNA Glycosylase | 2010 |